Treatment(s) now being considered-Chemotherapy Posts on Medivizor
Navigation Menu

Treatment(s) now being considered-Chemotherapy Posts on Medivizor

Is tandem stem cell transplantation effective in high risk relapsed/refractory Hodgkin lymphoma

Posted by on May 26, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the effect of tandem stem cell transplantation (SCT) in patients with high-risk relapsed/refractory Hodgkin Lymphoma (HL). The main finding was that patients treated with tandem SCT had greater progression-free survival than those without. Some background A SCT involves the transfer of stem cells into the patient to...

Read More

What are the outcomes for lymphoma patients who received TECAM chemotherapy before a stem cell transplant?

Posted by on Apr 18, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study analyzed data from patients with Hodgkin’s lymphoma (HL) and non-Hodgkin’s lymphoma (NHL) who received TECAM (etoposide, thiotepa, cytarabine, cyclophosphamide, melphalan) chemotherapy before autoSCT (autologous stem cell transplantation). The authors concluded that TECAM is an effective pre-autoSCT regimen for...

Read More

Can white blood cell count ratios help predict outcomes for newly diagnosed HL patients receiving PET2-mediated treatment?

Posted by on Apr 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study investigated the impact of white blood cell counts on the outcomes of newly diagnosed Hodgkin’s lymphoma (HL) patients receiving treatment mediated by PET2 (PET scanning after 2 cycles of chemotherapy). This study concluded that ratios of different types of white blood cells combined with PET2 can be a meaningful...

Read More

Does PET/CT scanning after one ABVD cycle better predict treatment outcomes than scanning after two cycles (iPET2)?

Posted by on Feb 20, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study analyzed PET/CT scans from new Hodgkin’s lymphoma patients after one (iPET1) or two (iPET2) cycles of ABVD chemotherapy. The study concluded that iPET2 is better than iPET1 at predicting ABVD outcomes in HL patients. Some background Interem PET/CT scanning is used to guide early treatment for new Hodgkin’s...

Read More

What are the outcomes for early-stage HL patients treated with ABVD and radiotherapy alone?

Posted by on Jan 16, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study determined the outcomes of early-stage classical Hodgkin’s lymphoma (HL) patients who received ABVD (doxorubicin, bleomycin, vinblastine, dacarbazine) chemotherapy and radiotherapy (RT) only. The study concluded that patients who showed a good partial response (tumor shrinkage) to ABVD chemotherapy were successfully...

Read More

How safe and effective is combined brentuximab vedotin and bendamustine in patients with relapsed/refractory HL?

Posted by on Jan 6, 2018 in Hodgkin's lymphoma | 0 comments

In a nutshell This study determined the safety and effectiveness of combined brentuximab vedotin (Adcetris) and bendamustine (Treanda) for relapsed or refractory (did not respond to treatment) Hodgkin’s lymphoma (HL). The study concluded that this combination is safe and effective, even for patients who already received intense anticancer...

Read More

FOLFOXIRI is associated with improved treatment outcomes in metastatic colorectal cancer patients

Posted by on Dec 30, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the effectiveness of the chemotherapy FOLFOXIRI as treatment for colorectal cancer. Researchers suggested that this chemotherapy is associated with improved treatment outcomes. Some background Chemotherapy is used in cancer patients to reduce symptoms and prolong survival. Chemotherapy drugs attack cancer...

Read More

Post-surgery complications can affect chemotherapy treatment after surgery in colorectal cancer

Posted by on Sep 28, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated the post-surgery factors that affect the use of chemotherapy after surgery in colorectal cancer patients. Researchers suggested that post-surgery complications are associated with delay or not receiving chemotherapy treatment.   Some background Surgery and post-surgery chemotherapy are the standard...

Read More